Linking PRMT5 to breast cancer stem cells: New therapeutic opportunities? (2018)
Attributed to:
The role of PRMT1-mediated arginine methylation during breast cancer development.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/23723556.2018.1441628
PubMed Identifier: 29876520
Publication URI: http://europepmc.org/abstract/MED/29876520
Type: Journal Article/Review
Volume: 5
Parent Publication: Molecular & cellular oncology
Issue: 3
ISSN: 2372-3556